These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12114041)

  • 1. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial.
    Oldfield WL; Larché M; Kay AB
    Lancet; 2002 Jul; 360(9326):47-53. PubMed ID: 12114041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects.
    Oldfield WL; Kay AB; Larché M
    J Immunol; 2001 Aug; 167(3):1734-9. PubMed ID: 11466398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects.
    Simons FE; Imada M; Li Y; Watson WT; HayGlass KT
    Int Immunol; 1996 Dec; 8(12):1937-45. PubMed ID: 8982778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1.
    Haselden BM; Syrigou E; Jones M; Huston D; Ichikawa K; Chapman MD; Kay AB; Larché M
    J Allergy Clin Immunol; 2001 Sep; 108(3):349-56. PubMed ID: 11544452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats.
    Pène J; Desroches A; Paradis L; Lebel B; Farce M; Nicodemus CF; Yssel H; Bousquet J
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):571-8. PubMed ID: 9802364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
    Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
    J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
    Alexander C; Ying S; B Kay A; Larché M
    Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.
    Senti G; Crameri R; Kuster D; Johansen P; Martinez-Gomez JM; Graf N; Steiner M; Hothorn LA; Grönlund H; Tivig C; Zaleska A; Soyer O; van Hage M; Akdis CA; Akdis M; Rose H; Kündig TM
    J Allergy Clin Immunol; 2012 May; 129(5):1290-6. PubMed ID: 22464647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Shamji MH; Singh I; Layhadi JA; Ito C; Karamani A; Kouser L; Sharif H; Tang J; Handijiev S; Parkin RV; Durham SR; Kostic A; Orengo JM; DeVeaux M; Kamal M; Stahl N; Yancopoulos GD; Wang CQ; Radin AR
    Am J Respir Crit Care Med; 2021 Jul; 204(1):23-33. PubMed ID: 33651675
    [No Abstract]   [Full Text] [Related]  

  • 11. Major cat allergen (Fel d I) levels in the homes of patients with asthma and their relationship to sensitization to cat dander.
    Quirce S; Dimich-Ward H; Chan H; Ferguson A; Becker A; Manfreda J; Simons E; Chan-Yeung M
    Ann Allergy Asthma Immunol; 1995 Oct; 75(4):325-30. PubMed ID: 7583847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for cat asthma.
    Van Metre TE; Marsh DG; Adkinson NF; Kagey-Sobotka A; Khattignavong A; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1988 Dec; 82(6):1055-68. PubMed ID: 2462581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides.
    Ali FR; Oldfield WL; Higashi N; Larché M; Kay AB
    Am J Respir Crit Care Med; 2004 Jan; 169(1):20-6. PubMed ID: 14500264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions.
    Haselden BM; Kay AB; Larché M
    J Exp Med; 1999 Jun; 189(12):1885-94. PubMed ID: 10377184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1.
    Reininger R; Varga EM; Zach M; Balic N; Lindemeier AD; Swoboda I; Grönlund H; van Hage M; Rumpold H; Valenta R; Spitzauer S
    Clin Exp Allergy; 2007 Jan; 37(1):116-24. PubMed ID: 17210049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization to cat allergens in non-cat owner patients with respiratory allergy.
    Gulbahar O; Sin A; Mete N; Kokuludag A; Kirmaz C; Sebik F
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):635-9. PubMed ID: 12839322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cat dander-specific T lymphocytes from atopic patients.
    van Neerven RJ; van de Pol MM; van Milligen FJ; Jansen HM; Aalberse RC; Kapsenberg ML
    J Immunol; 1994 Apr; 152(8):4203-10. PubMed ID: 8144980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.
    Haselden BM; Larché M; Meng Q; Shirley K; Dworski R; Kaplan AP; Bates C; Robinson DS; Ying S; Kay AB
    J Allergy Clin Immunol; 2001 Sep; 108(3):394-401. PubMed ID: 11544459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.